3.270 articles found

Multimodal neuroimaging and plasma biomarker evidence of white matter macrostructure loss in Parkinson’s dementia

Zarkali A, Hannaway N, McColgan P, Heslegrave A, Veleva E, Laban R, Zetterberg H, Lees A, Fox N, Weil R.

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024-12-01

Prospective cohort study to evaluate the diagnostic values of biomarkers in blood, cerebrospinal fluid and magnetic resonance imaging for mild cognitive impairment, Alzheimer's disease and Parkinson's disease in Hispanics

Fletcher J, Cano E, Ramírez A, Arosemena‐Aguero X, Araujo P, de Roux R, Balaguer R, Díaz M, Novarro‐Escudero N, Tamayo D, Aguilar L, Villarreal J, Mendoza J, Billingslea V, Juárez J, Courville K, Degracia S, Torres H, Benzadon A, Hammerschlag B, Saldaña A, Girón L, Solís D, Castillo L, Dondis D, Adames A, Crespo A, Araña S, Rodriguez C, López N, Oviedo D, Carreira M, Rangel G, Villarreal A, Britton G.

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024-12-01

MiR-19b-3p Serves as a Potential Diagnostic Biomarker for Parkinson's Disease.

Wu J, Cao W, Wei W, Zhang D, Li X, Wang Y, Chen X.

Clin Lab · 2024-12-01

DOI: 10.7754/clin.lab.2024.240639PMID: 39662006

Retinopathy in Parkinson's disease: A potential biomarker for early diagnosis and clinical assessment.

Xiao K, Li J, Zhou L, Liu X, Xiao Z, He R, Chu H, Tang Y, Liu P, Lu X.

Neuroscience · 2024-11-30

DOI: 10.1016/j.neuroscience.2024.11.073PMID: 39617167

KeyGAN: Synthetic keystroke data generation in the context of digital phenotyping.

Acien A, Morales A, Giancardo L, Vera-Rodriguez R, Holmes AA, Fierrez J, Arroyo-Gallego T.

Comput Biol Med · 2024-11-29

DOI: 10.1016/j.compbiomed.2024.109460PMID: 39615234

Digital Outcomes as Biomarkers of Disease Progression in Early Parkinson's Disease: A Systematic Review.

Rábano-Suárez P, Del Campo N, Benatru I, Moreau C, Desjardins C, Sánchez-Ferro Á, Fabbri M.

Mov Disord · 2024-11-29

DOI: 10.1002/mds.30056PMID: 39613480

Medication Management Initiatives Using Wearable Devices: Scoping Review.

Iino H, Kizaki H, Imai S, Hori S.

JMIR Hum Factors · 2024-11-27

DOI: 10.2196/57652PMID: 39602520

Human Leukocyte Antigen Polymorphism and Blood Biomarker Profiles in Parkinson's Disease: A Pilot Study in a Latvian Cohort.

Minibajeva O, Karelis G, Zolovs M, Ķēniņa V.

Biomedicines · 2024-11-27

DOI: 10.3390/biomedicines12122709PMID: 39767615

Integrated Transcriptomic and Machine Learning Analysis Identifies <i>EAF2</i> as a Diagnostic Biomarker and Key Pathogenic Factor in Parkinson's Disease.

Peng H, Cheng Y, Chen Q, Qin L.

Int J Gen Med · 2024-11-25

DOI: 10.2147/ijgm.s486214PMID: 39619132

Unveiling biomarker detection in Alzheimer's disease: a computational approach to microarray analysis.

Khan NS, Choudhary S, Ali M, Shawaz M, Lohnes BJ, Poddar NK.

3 Biotech · 2024-11-25

DOI: 10.1007/s13205-024-04159-4PMID: 39606011

Bioinformatics and Machine Learning-Based Identification of Critical Biomarkers and Immune Infiltration in Venous Thromboembolism.

Li Y, Deng H.

Int J Anal Chem · 2024-11-22

DOI: 10.1155/ianc/2202321PMID: 39618481

Modifications of DJ-1 in which pI shifts to acidic in red blood cells a potential biomarker for Parkinson's disease at early stages.

Matsuda K, Mita Y, Saigoh K, Saito Y, Noguchi N.

Free Radic Res · 2024-11-22

DOI: 10.1080/10715762.2024.2430536PMID: 39576630